YOLFTbeta
00

Jin Yang Pharmaceutical Co. Ltd

007370 · KQ · Healthcare / Drug Manufacturers - Specialty & Generic

3,425.00KRW+55.00 (+1.63%)

Price History

Full chart

Market Stats

Previous Close3,370.00
Open3,415.00
Day Range3,365.00 – 3,450.00
52-Week Range3,350.00 – 5,574.42
Volume23.85K
Market Cap56.04B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield3.78%
Beta0.34
50-Day Avg3,956.60
200-Day Avg4,431.80

About

Jin Yang Pharmaceutical Co., Ltd. engages in the pharmaceutical business in South Korea. The company offers crivix tablets, Eszol tablets, atolan tablets, prescription drugs, and over-the-counter drugs. It also offers antilipidemic, antiplatelet, gastrointestinal, and respiratory agents; antithrombotics; NSAIDs; menopause symptoms treatment; and stomatological products. The company also exports its products. Jin Yang Pharmaceutical Co., Ltd. was founded in 1971 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Jae-Joon Choi
  • Employees0
  • HeadquartersJinyang Pharm Building, Seoul, South Korea, Korea
  • Websitehttps://www.jinyangpharm.com

Leadership

  • Mr. Choi Yoon HwanFounder, President & Chairman · b. 1937
  • Mr. Jae-Joon ChoiCEO & Representative Director · b. 1970

Financials

Income Statement

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue45.24B40.15B36.13B43.45B46.86B47.35B48.81B62.84B76.26B94.11B113.33B120.69B
Growth (%)--11.25%-10.00%+20.25%+7.85%+1.04%+3.08%+28.74%+21.36%+23.40%+20.42%+6.49%
Cost of Revenue17.23B17.83B18.85B20.55B21.07B23.29B23.24B28.86B30.61B36.65B43.45B42.54B
Gross Profit28.00B22.32B17.28B22.90B25.79B24.06B25.57B33.98B45.65B57.46B69.88B78.15B
Gross Margin61.91%55.59%47.83%52.70%55.03%50.82%52.38%54.08%59.86%61.05%61.66%64.76%
Operating Expense21.88B23.54B27.33B29.02B24.33B24.28B22.02B27.02B34.19B48.16B58.45B75.62B
Operating Income6.12B-1.22B-10.05B-6.12B1.47B-216.33M3.55B6.96B11.46B9.30B11.43B2.53B
Operating Margin13.54%-3.04%-27.81%-14.08%3.13%-0.46%7.26%11.08%15.03%9.88%10.09%2.09%
EBITDA--------18.11B16.21B40.93B32.80B
EBITDA Margin--------23.75%17.22%36.12%27.18%
Net Income4.01B-1.00B-9.10B-5.77B933.15M1.65B3.68B9.54B12.31B12.66B29.69B22.29B
Net Income Margin8.87%-2.50%-25.18%-13.28%1.99%3.48%7.53%15.18%16.14%13.45%26.20%18.47%
Interest Expense000000162.88M208.28M1.29B1.37B1.86B2.29B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.33%0.33%1.68%1.46%1.64%1.90%

Balance Sheet

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets76.68B86.90B76.78B73.85B70.06B68.28B68.08B98.50B114.44B119.91B227.57B267.81B
Total Liabilities15.20B27.72B27.64B31.47B28.01B24.61B21.77B33.18B36.87B30.32B107.70B107.95B
Total Equity61.48B59.18B49.15B42.38B42.05B43.67B46.31B65.32B77.58B89.58B119.88B159.86B
Cash6.35B4.02B146.86M109.63M86.43M1.71B5.18B11.72B753.56M5.12B1.78B2.20B
Total Debt--14.77B--9.11B6.04B-----
Net Debt-----7.29B824.57M-9.16B2.41B77.50B74.22B

Cash Flow

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-3.08B-2.76B-13.47M-987.16M1.06B7.21B6.24B1.97B7.45B8.53B12.79B1.46B
Investing Cash Flow-2.46B-12.71B-2.63B-3.50B7.42B-1.02B1.37B-4.28B-12.83B3.24B-86.28B-
Financing Cash Flow1.43B13.13B-1.23B4.45B-8.50B-4.56B-4.15B8.85B-5.58B-7.40B70.15B-
Capital Expenditure3.03B14.52B4.08B1.18B327.39M736.71M1.36B2.52B3.22B1.53B947.22M3.67B
Free Cash Flow-----3.87B4.87B-752.94M2.81B7.00B11.85B-2.21B
Dividends Paid1.14B1.12B1.12B1.12B1.12B1.12B1.12B1.12B1.12B1.62B1.62B1.71B
FCF to OCF-----53.72%78.04%-38.21%37.68%82.03%92.60%-150.66%
Dividend Paid to FCF-----28.86%22.94%-148.45%39.83%23.09%13.67%-77.66%

Earnings

Report DateMar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate----------------------------------------------------------------------
EPS Actual45.95121.16283.95120.4273.45-35.7642.46197.0092.1012.62-105.3893.0922.13119.3590.94-11.2543.90-18.11118.82222.3990.6349.8716.64197.00100.39-19.81-5.65-164.79-162.9616.85-17.81-650.113.1733.6343.23-596.107.1667.1542.85-33.67113.3160.33-18.76-7.4630.1478.92118.94100.9367.74344.04189.02230.91153.58246.89477.92118.51228.50375.94314.4091.25151.47100.931592.00222.92192.89142.28-80.201367.28158.90154.91
Surprise----------------------------------------------------------------------
Timing----------------------------------------------------------------------

Key Statistics & Ratios

Market Cap56.04B
Enterprise Value124.65B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.45
Price / Book0.34
Revenue (TTM)124.61B
Gross Profit (TTM)82.26B
EBITDA6.35B
Profit Margin18.30%
Operating Margin12.91%
Return on Equity15.81%
Return on Assets0.94%
Shares Outstanding14.13M
Shares Float9.13M
Beta0.34
Dividend Yield3.78%
Dividend Rate150.00
Payout Ratio9.37%

Dividends

20251×
150.00Dec 29, 2025
20241×
150.00Dec 27, 2024
20231×
150.00Dec 27, 2023
20221×
150.00Dec 28, 2022
20211×
100.00Dec 29, 2021
20201×
100.00Dec 29, 2020
20191×
100.00Dec 27, 2019
20181×
100.00Dec 27, 2018
20171×
100.00Dec 27, 2017
20161×
100.00Dec 28, 2016
20151×
100.00Dec 29, 2015
20141×
100.00Dec 29, 2014
20131×
100.00Dec 27, 2013
20121×
100.00Dec 27, 2012
20111×
100.00Dec 28, 2011
20101×
100.00Dec 29, 2010
20091×
100.00Dec 29, 2009
20081×
100.00Dec 29, 2008
20071×
100.00Dec 27, 2007
20061×
100.00Dec 27, 2006
20051×
100.00Dec 28, 2005
20041×
94.55Dec 29, 2004
20031×
94.55Dec 29, 2003
20021×
71.10Dec 27, 2002

Stock Splits

  • Sep 2, 20053978:3761
  • Apr 21, 200510:1
  • May 19, 20035:4
  • Apr 9, 20031067:1003